Hoʻohana ʻia ka 2-((6-chloro-3-Methyl-2,4-dioxo-3,4-dihydropyriMidin-1(2H)-yl)Methyl)-4-fluorobenzonitrile ma ke ʻano he waena o Trelagliptin succinate.
ʻO Trogliptin succinate kahi dipeptidyl peptidase Ⅳ (DPP - Ⅳ) inhibitor i hoʻomohala ʻia e Takeda (Takeda Pharmaceutical Co., Ltd.) ma Iapana.Hiki iā ia ke koho a hoʻomau mau i ka DPP - Ⅳ a hoʻopaʻa i ka pae glucose koko.Hōʻike nā hoʻokolohua lapaʻau he palekana a maikaʻi ka lāʻau lapaʻau.Hoʻokahi manawa i ka pule hiki ke hoʻomalu pono i ke kiʻekiʻe o ka glucose koko a hoʻomaikaʻi i ka mālama ʻana i ka lāʻau lapaʻau o nā maʻi.I Mei, 2015, ua ʻae ʻia ka lāʻau lapaʻau e Iapana PMDA e helu ʻia no ka mālama ʻana i ka maʻi diabetes.